VIDEO of Peter Harrison's (CEO) presentation at ShareSoc on Monday:
www.piworld.co.uk/videos/2016/6/9/bioventix-bvxp-s...
A succinct presentation to understand what Bioventix (LON:BVXP) do.
• The product
• Revenue streams
• Stickiness of revenue
• Timelines to develop revenue streams
• Barriers to entry
• Threats
• The future
A sense of the culture of the company
The journey of the historic research that led to current products.
The pipeline of future products.
Peter Harrison is a 12% shareholder, Miton 14.5% and other institutional holders
Q&A at 38:55, with questions around possible threats covering:
• Impact of loss of NT proBNP, and replacement of revenues by Troponin
• Technological threats
• Time it’s taken to get Treponin to market
• The future of company
• Personalised medicine
• Collaborations with other organisations
